Clinical role of FDG-PET for HCC: Relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 582-586

  Kawamura, Etsushi ^a   Habu, Daiki ^a   Ohfuji, Satoko ^a   Fukushima, Wakaba ^a   Enomoto, Masaru ^a   Torii, Kenji ^a   Kawabe, Joji ^a   Kondo, Kyoko ^a   Tamori, Akihiro ^a   Kawada, Norifumi ^a   Shiomi, Susumu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Japan integrated staging score; Positron emission tomography with fluorine 18 fluorodeoxyglucose; Tumor node metastasis stage score

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CALCULATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE METABOLISM; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOACTIVITY; SURVIVAL RATE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 44349132760     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Marrero JA: Hepatocellular carcinoma. Curr Opin Gastroenterol 2005; 21:308-312.
2. Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003; 38:207-215.
3. Liver Cancer Study Group of Japan: The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd English Edition. Tokyo, Japan: Kanehara & Co., Ltd., 2003.
4. Lin WY, Tsai SC, Hung GU: Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun 2005; 26:315-321.
5. Cox DR: Regression models and life-tables. J R Stat Soc B 1972; 34:187-220.
6. Schlichting P, Christensen E, Andersen PK, Fauerholdt L, Juhl E, Poulsen H: Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3:889-895.
7. Holford TR: Life tables with concomitant information. Biometrics 1976; 32:587-597.
8. Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52:203-224.
9. Lee JD, Yang WI, Park YN, Kim KS, Choi JS, Yun M: Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased 18F-FDG uptake. J Nucl Med 2005; 46:1753-1759.
10. Jeng LB, Changlai SP, Shen YY, Lin CC, Tsai CH, Kao CH: Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterology 2003; 50:2154-2156.
11. Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, et al: Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 1999; 94:3314-3319.
12. Garcia G, Keeffe EB: Liver biopsy in chronic hepatitis C: routine or selective. Am J Gastroenterol 2001; 96:3053-3055.
13. Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee HS, et al: Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 2005; 20:765-771.
14. Aoyagi Y, Mita Y, Suda T, Kawai K, Kuroiwa T, Igarashi M, et al: The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes. Hepatol Res 2002; 23:287.
15. Omagari K, Honda S, Kadokawa Y, Isomoto H, Takeshima F, Hayashida K, et al: Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma. J Gastroenterol Hepatol 2004; 19:805-811.
16. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol 2004; 39:961-968.
17. Schoder H, Erdi YE, Larson SM, Yeung HW: PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003; 30:1419-1437.
18. Llovet JM: Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40:225-235.